Goldman Sachs
ASMB icon

Goldman Sachs’s Assembly Biosciences ASMB Stock Holding History

Goldman Sachs’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1M Buy
36,205
+1,411
+4% +$40.2K ﹤0.01% 5085
2025
Q4 		$1.18M Buy
34,794
+17,138
+97% +$552K ﹤0.01% 5008
2025
Q3 		$452K Buy
+17,656
New +$387K ﹤0.01% 5557
2023
Q1 		– Sell
-4,596
Closed -$71.7K – 5906
2022
Q4 		$71.7K Sell
4,596
-1,524
-25% -$26.1K ﹤0.01% 5542
2022
Q3 		$120K Sell
6,120
-277
-4% -$6.7K ﹤0.01% 5639
2022
Q2 		$161K Sell
6,397
-3,917
-38% -$90.1K ﹤0.01% 5711
2022
Q1 		$255K Buy
10,314
+5,701
+124% +$122K ﹤0.01% 5748
2021
Q4 		$129K Sell
4,613
-6,334
-58% -$208K ﹤0.01% 6060
2021
Q3 		$457K Sell
10,947
-4,863
-31% -$204K ﹤0.01% 5250
2021
Q2 		$736K Buy
15,810
+2,512
+19% +$124K ﹤0.01% 4980
2021
Q1 		$734K Buy
13,298
+3,321
+33% +$220K ﹤0.01% 4840
2020
Q4 		$725K Buy
9,977
+5,394
+118% +$633K ﹤0.01% 4406
2020
Q3 		$904K Sell
4,583
-2,884
-39% -$726K ﹤0.01% 4150
2020
Q2 		$2.09M Sell
7,467
-3,239
-30% -$756K ﹤0.01% 3425
2020
Q1 		$1.91M Buy
10,706
+6,228
+139% +$1.34M ﹤0.01% 3339
2019
Q4 		$1.1M Sell
4,478
-1,199
-21% -$221K ﹤0.01% 4063
2019
Q3 		$670K Buy
5,677
+2,796
+97% +$423K ﹤0.01% 4289
2019
Q2 		$466K Buy
2,881
+855
+42% +$163K ﹤0.01% 4428
2019
Q1 		$479K Buy
2,026
+268
+15% +$67.9K ﹤0.01% 4433
2018
Q4 		$477K Sell
1,758
-1
-0.1% -$289 ﹤0.01% 4389
2018
Q3 		$784K Sell
1,759
-4,903
-74% -$2.3M ﹤0.01% 4182
2018
Q2 		$3.13M Buy
6,662
+6,202
+1,348% +$3.28M ﹤0.01% 3288
2018
Q1 		$271K Sell
460
-177
-28% -$110K ﹤0.01% 4833
2017
Q4 		$346K Sell
637
-327
-34% -$148K ﹤0.01% 5091
2017
Q3 		$404K Sell
964
-2,704
-74% -$829K ﹤0.01% 5258
2017
Q2 		$909K Sell
3,668
-1,464
-29% -$412K ﹤0.01% 4554
2017
Q1 		$1.57M Buy
+5,132
New +$1.26M ﹤0.01% 3985
2016
Q4 		– Sell
-1,908
Closed -$165K – 6882
2016
Q3 		$165K Sell
1,908
-127
-6% -$9.81K ﹤0.01% 5948
2016
Q2 		$136K Buy
+2,035
New +$134K ﹤0.01% 5962
2015
Q4 		– Sell
-1,042
Closed -$120K – 7128
2015
Q3 		$120K Buy
1,042
+46
+5% +$8.09K ﹤0.01% 6372
2015
Q2 		$230K Sell
996
-499
-33% -$96.3K ﹤0.01% 6012
2015
Q1 		$238K Buy
1,495
+609
+69% +$82.4K ﹤0.01% 5855
2014
Q4 		$84K Sell
886
-301
-25% -$29.7K ﹤0.01% 6641
2014
Q3 		$117K Sell
1,187
-66
-5% -$5.85K ﹤0.01% 6508
2014
Q2 		$98K Sell
1,253
-511
-29% -$36.2K ﹤0.01% 6555
2014
Q1 		$135K Buy
+1,764
New +$275K ﹤0.01% 6282

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Goldman Sachs's ASMB Position: Q1 2026 in Review

Goldman Sachs increased its Assembly Biosciences (ASMB) stake by 4.1% in Q1 2026, buying an estimated $40.2K and bringing the position to 36,205 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #5085.

Goldman Sachs first reported a position in ASMB in Q1 2014 and has held it in 36 quarters since. The position peaked at $3.13M in Q2 2018. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Goldman Sachs held 36,205 shares of Assembly Biosciences worth $1M as of Q1 2026.
  • Goldman Sachs bought 1,411 Assembly Biosciences shares in Q1 2026, an estimated $40.2K.
  • Assembly Biosciences made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5085 holding.
  • Goldman Sachs first reported a position in Assembly Biosciences in Q1 2014 and has held it in 36 quarters since.
  • Goldman Sachs's Assembly Biosciences position peaked at $3.13M in Q2 2018.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.